-
1 Comment
Epsilon Healthcare Limited is currently in a long term downtrend where the price is trading 11.9% below its 200 day moving average.
From a valuation standpoint, the stock is 96.5% cheaper than other stocks from the Industrials sector with a price to sales ratio of 4.5.
Epsilon Healthcare Limited's total revenue rose by 31.2% to $3M since the same quarter in the previous year.
Its net income has increased by 6.0% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 2.6% to $-3M since the same quarter in the previous year.
Based on the above factors, Epsilon Healthcare Limited gets an overall score of 3/5.
Industry | Farm & Heavy Construction Machinery |
---|---|
Sector | Industrials |
ISIN | AU000000THC4 |
CurrencyCode | AUD |
Exchange | AU |
Dividend Yield | 0.0% |
---|---|
Target Price | None |
Market Cap | 44M |
Beta | 1.35 |
PE Ratio | None |
THC Global Group Limited provides medicinal cannabis products to patients in Australia and internationally. The company operates through two segments, Manufacture and Distribution of Hydroponics Equipment, Materials and Nutrients; and Development and Delivery of Medicinal Cannabis. Its hydroponics products include lighting and power supplies, lighting relays and climate controls, ventilation and trimming products, extraction bags, plant rotation systems, eyewear, nutrients and accessories, etc. THC Global Group Limited has a strategic alliance with BOL Pharma-Israel; strategic partnership with Ascent Industries Corp?Canada, Sinapse and Pharma programs, and Anspec; distribution agreement with Endoca-Europe; and partnership with Medicinal Cannabis Industry Australia. The company was formerly known as The Hydroponics Company Limited and changed its name to THC Global Group Limited in November 2018. THC Global Group Limited was founded in 2016 and is based in Sydney, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for THC.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024